EN | |


World-Class Biologics Manufacturing Capabilities

To support the commercialisation of the Group's proprietary products and its partners', Uni-Bio Science Group's subsidiaries own and operate biologics manufacturing facilities in Beijing and Shenzhen which strictly adhere to the conditions and standards of the international Good Manufacturing Practices (GMPs).

The Group has invested over HKD240M in equipping its manufacturing facilities with the latest equipment, including multiple bioreactors, from leading international companies.

At its certified cGMP (China Good Manufacturing Practice) manufacturing plants in Shenzhen and Beijing, Uni-Bio Science produces and packages innovative products to be delivered to patients across China.

Uni-Bio Science continues to invest significantly in its manufacturing capabilities to ensure that all plants comply with global standards, ensuring stringent product quality control and manufacturing capacity.Recently the waste water treatment facilities in Beijing plant was upgraded to improve compliance to environment policy.

Uni-Bio Science's biologics manufacturing facilities :

Beijing GeneTech

Investment confirmed in multifunction production line for injection pen and prefilled products

High speed tablet and capsule production lines

50L and 500L bioreactors

12,500 sq-meter total floor space capable of producing both chemical and biologic drugs, compliant to latest GMP standards

Dedicated R&D and new formulation development centres

Shenzen Watsin

Liquid ophthalmic and dermatological preparations in spray and drops
World class packaging facilities

Two 50L bioreactors

8,100m2 total floor space producing two biologic class I EGF drugs, compliant to latest GMP standards

Temperature-controlled supply chain facilities